13F Holdings
中文EN

VMD VIEMED HEALTHCARE, INC.

Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1729149 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.8%
TTM net income YoY14.8%
TTM EPS YoY11.8%
Revenue 3-yr CAGR22.3%
Net income 3-yr CAGR19.3%

Margins

Gross margin57.4%
Operating margin7.8%
Net margin5.0%
FCF margin6.9%
EBITDA margin12.9%

Returns

ROE11.0%
ROA7.6%
ROIC (approx.)11.8%
Asset turnover1.51x

Leverage & solvency

Liabilities / assets26.8%
Debt / equity0.03x
Current ratio1.25x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.45x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue10.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$270.28M$224.26M$183.01M$138.83M$117.06M
Cost of revenue$114.82M$91.05M$70.22M$54.15M$43.65M
Gross profit$155.46M$133.20M$112.78M$84.68M$73.41M
R&D expense$3.02M$3.07M$2.78M$2.70M$2.11M
SG&A expense$121.37M$106.20M$87.88M$68.16M$54.89M
Operating income$22.95M$17.90M$14.33M$8.25M$11.58M
Pretax income$21.77M$16.17M$14.39M$8.99M$12.50M
Income tax$6.39M$4.76M$4.15M$2.77M$3.38M
Net income$14.93M$11.27M$10.24M$6.22M$9.13M
EBITDA$51.56M$43.27M$36.19M$23.88M$22.89M
EPS (basic)0.380.290.270.160.23
EPS (diluted)0.370.280.250.160.22
Weighted avg. shares (diluted)40.82M40.81M40.38M39.81M40.68M
Balance sheet
Cash & equivalents$13.50M$17.54M$12.84M$16.91M$28.41M
Receivables$25.59M$24.91M$18.45M$15.38M$12.82M
Inventory$5.05M$4.32M$4.63M$3.57M$2.46M
Current assets$48.49M$52.88M$38.37M$39.74M$47.31M
PP&E, net$78.78M$76.28M$73.58M$67.74M$62.85M
Goodwill$58.94M$32.99M$29.77M$0—
Intangibles$1.28M$848,000$567,000$0—
Total assets$199.15M$177.07M$154.90M$117.04M$117.96M
Current liabilities$41.06M$37.33M$32.12M$18.86M$17.81M
Short-term debt$1.09M$409,000$1.07M$0$1.48M
Long-term debt$11.29M$3.59M$6.00M$0$4.31M
Total debt$12.38M$4.00M$7.07M$0$5.79M
Total liabilities$55.63M$43.77M$41.00M$19.95M$23.14M
Shareholders' equity$141.54M$131.39M$113.89M$97.09M$94.82M
Net debt-$1.12M-$13.54M-$5.76M-$16.91M-$22.62M
Shares outstanding38.02M39.13M38.51M38.05M39.64M
Cash flow statement
Operating cash flow$51.92M$39.09M$45.21M$27.75M$22.49M
Capital expenditure$39.98M$37.77M$26.09M$22.90M$19.74M
Free cash flow$11.93M$1.32M$19.12M$4.85M$2.75M
Investing cash flow-$50.17M-$30.70M-$52.11M-$23.98M-$19.75M
Financing cash flow-$5.79M-$3.69M$2.83M-$15.27M-$5.32M
Depreciation & amortization$28.61M$25.37M$21.86M$15.63M$11.31M
Stock-based compensation$9.13M$6.29M$5.85M$5.20M$5.15M
Share buybacks$13.22M$0$0$9.57M$0

Free plan shows the latest 5 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.